Catalyst Biosciences Reports First Quarter 2021 Operating & Financial Results and Provides a Corporate Update
Published: May 06, 2021 SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc.. (NASDAQ: CBIO) today announced its operating and financial results for the first quarter ended March 31, 2021 and provided a corporate update. “We made significant progress across our Protease Medicines platform, specifically in our complement and hemostasis programs. We are preparing to initiate an observational trial in patients who have diseases related to CFI deficiency in...
United States Viia Fviia Nassim Usman Glanzmann Thrombasthenia Systemic Complement Program Company Phase
Source: biospace.com